Market Cap 291.22M
Revenue (ttm) 1.75M
Net Income (ttm) -34.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,950.29%
Debt to Equity Ratio -0.07
Volume 3,000
Avg Vol 6,748
Day's Range N/A - N/A
Shares Out 293.42M
Stochastic %K 47%
Beta 0.09
Analysts Strong Buy
Price Target N/A

Company Profile

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibo...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 416-626-3233
Fax: 866-332-2699
Address:
135 The West Mall, Unit 2, Toronto, Canada
Latest News on EDTXF
No data available.